0
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Analyzing the infertility burden of polycystic ovarian syndrome in China: A comprehensive age-period-cohort analysis with future burden prediction (1990–2030)

, , , &
Article: 2362251 | Received 03 Mar 2024, Accepted 27 May 2024, Published online: 11 Jul 2024

References

  • Luo D, Yan X, Xu R, et al. Chinese trends in adolescent marriage and fertility between 1990 and 2015: a systematic synthesis of national and subnational population data. Lancet Glob Health. 2020;8(7):e954–e64. doi:10.1016/S2214-109X(20)30130-3.
  • Zhu C, Yan L, He C, et al. Incidence and risk factors of infertility among couples who desire a first and second child in Shanghai, China: a facility-based prospective cohort study. Reprod Health. 2022;19(1):155. doi:10.1186/s12978-022-01459-x.
  • Carson SA, Kallen AN. Diagnosis and management of infertility: a review. JAMA. 2021;326(1):65–76. doi:10.1001/jama.2021.4788.
  • Bala R, Singh V, Rajender SA-O, et al. Environment, lifestyle, and female infertility. Reprod Sci. 2021;28(3):617–638. doi:10.1007/s43032-020-00279-3.
  • Shi Z, Nie H, Geng L, et al. Evaluating health-related quality of life and subjective wellbeing among infertility patients: a cross-sectional study in mainland China. Qual Life Res. 2023;32(5):1469–1480. doi:10.1007/s11136-022-03330-9.
  • Wang L, Tang Y, Wang Y. Predictors and incidence of depression and anxiety in women undergoing infertility treatment: a cross-sectional study. PLoS One. 2023;18(4):e0284414. doi:10.1371/journal.pone.0284414.
  • Lau JT, Wang Q, Fau- Cheng Y, et al. Infertility-related perceptions and responses and their associations with quality of life among rural chinese infertile couples. J Sex Marital Ther. 2008;34(3):248–267. doi:10.1080/00926230701866117.
  • Bozdag G, Mumusoglu S, Zengin D, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841–2855. doi:10.1093/humrep/dew218.
  • Joshi A. PCOS stratification for precision diagnostics and treatment. Front Cell Dev Biol. 2024;12:1358755. doi:10.1530/JOE-23-0342.
  • Zhu T, Goodarzi MO. Causes and consequences of polycystic ovary syndrome: insights from mendelian randomization. J Clin Endocrinol Metab. 2022;107(3):e899–e911. doi:10.1210/clinem/dgab757.
  • Woolner AM, Bhattacharya S. Intergenerational trends in reproduction: infertility and pregnancy loss. Best Pract Res Clin Obstet Gynaecol. 2023;86:102305. doi:10.1016/j.bpobgyn.2022.102305.
  • Zegers-Hochschild F, Adamson GD, Dyer S, et al. The international glossary on infertility and fertility care, 2017. Fertil Steril. 2017;108(3):393–406. doi:10.1016/j.fertnstert.2017.06.005.
  • Garolla A, Pizzol D, Carosso AR, et al. Practical clinical and diagnostic pathway for the investigation of the infertile couple. Front Endocrinol (Lausanne). 2020;11:591837. doi:10.3389/fendo.2020.591837.
  • De Geyter C, Calhaz-Jorge C, Kupka MS, et al. ART in Europe, 2014: results generated from European registries by ESHRE: the European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod. 2018;33(9):1586–1601. doi:10.1093/humrep/dey242.
  • Yu J, Fu Y, Zeng L, et al. Burden of female infertility in China from 1990 to 2019: a temporal trend analysis and forecasting, and comparison with the global level. Sex Health. 2023;20(6):577–584. doi:10.1071/SH23029.
  • Safiri S, Noori M, Nejadghaderi SA, et al. Prevalence, incidence and years lived with disability due to polycystic ovary syndrome in 204 countries and territories, 1990-2019. Hum Reprod. 2022;37(8):1919–1931. doi:10.1093/humrep/deac091.
  • Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222. doi:10.1016/S0140-6736(20)30925-9.
  • Vosoughi K, Stovner LJ, Steiner TJ, et al. The burden of headache disorders in the Eastern Mediterranean Region, 1990-2016: findings from the Global Burden of Disease study 2016. J Headache Pain. 2019;20(1):40. doi:10.1186/s10194-019-0990-3.
  • Stevens GA, Alkema L, Black RE, et al. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. PLoS Med. 2016;13(6):e1002056. doi:10.1371/journal.pmed.1002056.
  • Lee TC, Dean CB, Semenciw R. Short-term cancer mortality projections: a comparative study of prediction methods. Stat Med. 2011;30(29):3387–3402. doi:10.1002/sim.4373.
  • Notaro ALG, Neto FA-OX. The use of metformin in women with polycystic ovary syndrome: an updated review. J Assist Reprod Genet. 2022;39(3):573–579. doi: 10.1007/s10815-022-02429-9.
  • Cohen AM, Ye XY, Colgan TJ, et al. Comparing endometrial receptivity array to histologic dating of the endometrium in women with a history of implantation failure. Syst Biol Reprod Med. 2020;66(6):347–354. doi:10.1080/19396368.2020.1824032.
  • Stener-Victorin E, Padmanabhan V, Walters KA, et al. Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome. Endocr Rev. 2020;41(4):bnaa010. doi:10.1210/endrev/bnaa010.
  • Risal S, Pei Y, Lu H, et al. Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome. Nat Med. 2019;25(12):1894–1904. doi:10.1038/s41591-019-0666-1.
  • Venkatesh SS, Ferreira T, Benonisdottir S, et al. Obesity and risk of female reproductive conditions: A Mendelian randomisation study. PLoS Med. 2022;19(2):e1003679. doi:10.1371/journal.pmed.1003679.
  • Shorakae S, Ranasinha S, Abell S, et al. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS. Clin Endocrinol (Oxf). 2018;89(5):628–633. doi:10.1111/cen.13808.
  • Qi J, Wang W, Zhu Q, et al. Local cortisol elevation contributes to endometrial insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab. 2018;103(7):2457–2467. doi:10.1210/jc.2017-02459.
  • Steiner N, Ates S, Shaulov T, et al. A comparison of IVF outcomes transferring a single ideal blastocyst in women with polycystic ovary syndrome and normal ovulatory controls. Arch Gynecol Obstet. 2020;302(6):1479–1486. doi:10.1007/s00404-020-05699-9.
  • Wang Y, Xue H, Sun M, et al. Prevention and control of obesity in China. Lancet Glob Health. 2019;7(9):e1166-e7. doi:10.1016/S2214-109X(19)30276-1.
  • Mathis BA-O, Tanaka K, Hiramatsu Y. Factors of obesity and metabolically healthy obesity in Asia. Medicina (Kaunas). 2022;58(9):1271. doi:10.3390/medicina58091271.
  • Szczuko M, Kikut J, Szczuko U, et al. Nutrition strategy and life style in polycystic ovary syndrome-narrative review. Nutrients. 2021;13(7):2452. doi:10.3390/nu13072452.
  • Yang Y, Deng H, Li T, et al. The mental health of Chinese women with polycystic ovary syndrome is related to sleep disorders, not disease status. J Affect Disord. 2021;282:51–57. doi:10.1016/j.jad.2020.12.084.
  • Yang R, Li Q, Zhou Z, et al. Changes in the prevalence of polycystic ovary syndrome in China over the past decade. Lancet Reg Health West Pac. 2022;25:100494. doi:10.1016/j.lanwpc.2022.100494.
  • Group ECW, ESHRE Capri Workshop Group. A prognosis-based approach to infertility: understanding the role of time. Hum Reprod. 2017;32(8):1556–1559. doi:10.1093/humrep/dex214.
  • Smiechowicz J, Skoczynska A, Nieckula-Szwarc A, et al. Occupational mercury vapour poisoning with a respiratory failure, pneumomediastinum and severe quadriparesis. SAGE Open Med Case Rep. 2017;5:2050313X17695472. doi:10.1177/2050313X17695472.
  • Wang L, Zhu Y, Wang T, et al. Feasibility analysis of incorporating infertility into medical insurance in China. Front Endocrinol. 2022;13:967739. doi:10.3389/fendo.2022.967739.
  • Farquhar CM, Bhattacharya S, Repping S, et al. Female subfertility. Nat Rev Dis Primers. 2019;5(1):7. doi:10.1038/s41572-018-0058-8.
  • Liu Q, Guo Y. Regional differences of individual and allocation efficiencies of health resources in China. Front Public Health. 2023;11:1306148. doi:10.3389/fpubh.2023.1306148.
  • Bai F, Wang DY, Fan YJ, et al. Assisted reproductive technology service availability, efficacy and safety in mainland China: 2016. Hum Reprod. 2020;35(2):446–452. doi:10.1093/humrep/dez245.
  • Jingtong Q, Liang L. National Medical Insurance Bureau: four provinces have included assisted reproduction in medical insurance reimbursement: CCTV network; 2024. Available from: https://news.cctv.com/2024/03/30/ARTIaH3Lj01Em9w1Zgzm60e9240330.shtml.